Retraction Note: The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.

Autor: De Iuliis F; Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Taglieri L; Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Salerno G; Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Giuffrida A; Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Milana B; Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Giantulli S; Department of Molecular Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Carradori S; Department of Pharmacy, BG. D'Annunzio University of Chieti-Pescara, Via dei Vestini 31, Chieti, 66100, Italy., Silvestri I; Department of Molecular Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy., Scarpa S; Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, Rome, 00161, Italy. susanna.scarpa@uniroma1.it.
Jazyk: angličtina
Zdroj: Investigational new drugs [Invest New Drugs] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1007/s10637-024-01469-5
Databáze: MEDLINE
Externí odkaz: